Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities

Abstract Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guidel...

Full description

Saved in:
Bibliographic Details
Published in:Geburtshilfe und Frauenheilkunde Vol. 82; no. 2; pp. 181 - 205
Main Authors: Fehm, Tanja, Stübs, Frederik A., Koch, Martin C., Mallmann, Peter, Dannecker, Christian, Dietl, Anna, Sevnina, Anna, Mergel, Franziska, Lotz, Laura, Ehret, Anne, Gantert, Daniel, Martignoni, Franca, Cieslik, Jan-Philipp, Menke, Jan, Ortmann, Olaf, Stromberger, Carmen, Oechsle, Karin, Hornemann, Beate, Mumm, Friederike, Grimm, Christoph, Sturdza, Alina, Wight, Edward, Loessl, Kristina, Golatta, Michael, Hagen, Volker, Dauelsberg, Timm, Diel, Ingo, Münstedt, Karsten, Merz, Eberhard, Vordermark, Dirk, Lindel, Katja, Wittekind, Christian, Küppers, Volkmar, Lellé, Ralph, Neis, Klaus, Griesser, Henrik, Pöschel, Birgit, Steiner, Manfred, Freitag, Ulrich, Gilster, Tobias, Schmittel, Alexander, Friedrich, Michael, Haase, Heidemarie, Gebhardt, Marion, Kiesel, Ludwig, Reinhardt, Michael, Kreißl, Michael, Kloke, Marianne, Horn, Lars-Christian, Wiedemann, Regina, Marnitz, Simone, Letsch, Anne, Zraik, Isabella, Mangold, Bernhard, Möckel, Jochen, Alt, Céline, Wimberger, Pauline, Hillemanns, Peter, Paradies, Kerstin, Mustea, Alexander, Denschlag, Dominik, Henscher, Ulla, Tholen, Reina, Wesselmann, Simone, Beckmann, Matthias W.
Format: Journal Article
Language:English
Published: Rüdigerstraße 14, 70469 Stuttgart, Germany Georg Thieme Verlag KG 01-02-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Abstract Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process used to update the 2014 S3-guideline was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or – if evidence was lacking – on the consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which would take account of more recently published literature and the recent appraisal of new evidence. Recommendations The short version of this guideline consists of recommendations and statements on palliative therapy and follow-up of patients with cervical cancer. The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis. Zusammenfassung Ziel Im März 2021 erschien das Update der interdisziplinären S3-Leitlinie für die Diagnostik, Therapie und Nachsorge der Patientinnen mit Zervixkarzinom (AWMF-Registernummer: 032/033OL). Die Leitlinienarbeit ist von der Deutschen Krebshilfe im Rahmen des Leitlinienprogramms Onkologie gefördert. Die Koordination erfolgte durch die Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Arbeitsgemeinschaft Onkologische Gynäkologie (AGO) der Deutschen Krebsgesellschaft (DKG). Methoden Der Aktualisierungsprozess der S3-Leitlinie aus dem Jahre 2014 basierte entweder auf der Aufarbeitung der verfügbaren Evidenz nach den Kriterien der evidenzbasierten Medizin, einer Adaptierung von vorhandenen evidenzbasierten nationalen und internationalen Leitlinien oder – bei Fehlen einer Evidenzgrundlage – auf dem Konsens der beteiligten Fachexperten. Nach anfänglicher Sichtung der aktuellen Literatur nach vorgegebenem Algorithmus wurden mehrere Felder identifiziert, die im Gegensatz zur Vorläuferversion aus dem September 2014, neue Empfehlungen oder Statements benötigten, um der aktuell publizierten Literatur und der Evidenzaufarbeitung Genüge zu tun. Empfehlungen Die Kurzversion dieser Leitlinie beinhaltet Empfehlungen und Statements zur palliativen Therapie und Nachsorge von Patientinnen mit Zervixkarzinom. Zu den wesentlichen Neuerungen durch die Aktualisierung der Leitlinie gehören die 2018 neu publizierte FIGO-Klassifikation, das offene radikale Vorgehen bei Zervixkarzinom bis Stadium FIGO IB1 sowie der Einsatz der Sentinel-Lymphknoten-Technik bis Tumoren ≤ 2 cm. Weitere Änderungen betreffen den Einsatz des PET-CTs, neue Optionen in der Strahlentherapie (z. B. intensitätsmodulierte Strahlentherapie, Image-guided adaptive Brachytherapie) und medikamentöse Therapien in der Rezidiv- bzw. metastasierten Situation.
AbstractList Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process used to update the 2014 S3-guideline was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or - if evidence was lacking - on the consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which would take account of more recently published literature and the recent appraisal of new evidence. Recommendations The short version of this guideline consists of recommendations and statements on palliative therapy and follow-up of patients with cervical cancer. The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis.Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process used to update the 2014 S3-guideline was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or - if evidence was lacking - on the consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which would take account of more recently published literature and the recent appraisal of new evidence. Recommendations The short version of this guideline consists of recommendations and statements on palliative therapy and follow-up of patients with cervical cancer. The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis.
Abstract Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process used to update the 2014 S3-guideline was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or – if evidence was lacking – on the consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which would take account of more recently published literature and the recent appraisal of new evidence. Recommendations The short version of this guideline consists of recommendations and statements on palliative therapy and follow-up of patients with cervical cancer. The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis. Zusammenfassung Ziel Im März 2021 erschien das Update der interdisziplinären S3-Leitlinie für die Diagnostik, Therapie und Nachsorge der Patientinnen mit Zervixkarzinom (AWMF-Registernummer: 032/033OL). Die Leitlinienarbeit ist von der Deutschen Krebshilfe im Rahmen des Leitlinienprogramms Onkologie gefördert. Die Koordination erfolgte durch die Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Arbeitsgemeinschaft Onkologische Gynäkologie (AGO) der Deutschen Krebsgesellschaft (DKG). Methoden Der Aktualisierungsprozess der S3-Leitlinie aus dem Jahre 2014 basierte entweder auf der Aufarbeitung der verfügbaren Evidenz nach den Kriterien der evidenzbasierten Medizin, einer Adaptierung von vorhandenen evidenzbasierten nationalen und internationalen Leitlinien oder – bei Fehlen einer Evidenzgrundlage – auf dem Konsens der beteiligten Fachexperten. Nach anfänglicher Sichtung der aktuellen Literatur nach vorgegebenem Algorithmus wurden mehrere Felder identifiziert, die im Gegensatz zur Vorläuferversion aus dem September 2014, neue Empfehlungen oder Statements benötigten, um der aktuell publizierten Literatur und der Evidenzaufarbeitung Genüge zu tun. Empfehlungen Die Kurzversion dieser Leitlinie beinhaltet Empfehlungen und Statements zur palliativen Therapie und Nachsorge von Patientinnen mit Zervixkarzinom. Zu den wesentlichen Neuerungen durch die Aktualisierung der Leitlinie gehören die 2018 neu publizierte FIGO-Klassifikation, das offene radikale Vorgehen bei Zervixkarzinom bis Stadium FIGO IB1 sowie der Einsatz der Sentinel-Lymphknoten-Technik bis Tumoren ≤ 2 cm. Weitere Änderungen betreffen den Einsatz des PET-CTs, neue Optionen in der Strahlentherapie (z. B. intensitätsmodulierte Strahlentherapie, Image-guided adaptive Brachytherapie) und medikamentöse Therapien in der Rezidiv- bzw. metastasierten Situation.
This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( , DGGG) and the Working Group on Gynecological Oncology ( , AGO) of the German Cancer Society ( , DKG). The process used to update the 2014 S3-guideline was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or - if evidence was lacking - on the consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which would take account of more recently published literature and the recent appraisal of new evidence. The short version of this guideline consists of recommendations and statements on palliative therapy and follow-up of patients with cervical cancer. The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis.
Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in March 2021. The work on the updated guideline was funded by German Cancer Aid (Deutsche Krebshilfe) as part of the German Guideline Program in Oncology. The guideline was coordinated by the German Society of Gynecology and Obstetrics ( Deutsche Gesellschaft für Gynäkologie und Geburtshilfe , DGGG) and the Working Group on Gynecological Oncology ( Arbeitsgemeinschaft Gynäkologische Onkologie , AGO) of the German Cancer Society ( Deutsche Krebsgesellschaft , DKG). Method The process used to update the 2014 S3-guideline was based on an appraisal of the available evidence using the criteria of evidence-based medicine, adaptations of existing evidence-based national and international guidelines or – if evidence was lacking – on the consensus of the specialists involved in compiling the update. After an initial review of the current literature was carried out according to a prescribed algorithm, several areas were identified which, in contrast to the predecessor version from September 2014, required new recommendations or statements which would take account of more recently published literature and the recent appraisal of new evidence. Recommendations The short version of this guideline consists of recommendations and statements on palliative therapy and follow-up of patients with cervical cancer. The most important aspects included in this updated guideline are the new FIGO classification published in 2018, the radical open surgery approach used to treat cervical cancer up to FIGO stage IB1, and the use of the sentinel lymph node technique for tumors ≤ 2 cm. Other changes include the use of PET-CT, new options in radiotherapy (e.g., intensity-modulated radiotherapy, image-guided adaptive brachytherapy), and drug therapies to treat recurrence or metastasis.
Author Griesser, Henrik
Wight, Edward
Marnitz, Simone
Wimberger, Pauline
Hillemanns, Peter
Zraik, Isabella
Stübs, Frederik A.
Hornemann, Beate
Loessl, Kristina
Mumm, Friederike
Mallmann, Peter
Alt, Céline
Münstedt, Karsten
Mangold, Bernhard
Menke, Jan
Ehret, Anne
Letsch, Anne
Neis, Klaus
Beckmann, Matthias W.
Lotz, Laura
Gebhardt, Marion
Kloke, Marianne
Ortmann, Olaf
Oechsle, Karin
Küppers, Volkmar
Lellé, Ralph
Möckel, Jochen
Martignoni, Franca
Mergel, Franziska
Grimm, Christoph
Sevnina, Anna
Denschlag, Dominik
Kreißl, Michael
Wittekind, Christian
Haase, Heidemarie
Hagen, Volker
Reinhardt, Michael
Fehm, Tanja
Cieslik, Jan-Philipp
Pöschel, Birgit
Horn, Lars-Christian
Kiesel, Ludwig
Sturdza, Alina
Koch, Martin C.
Gilster, Tobias
Merz, Eberhard
Stromberger, Carmen
Wesselmann, Simone
Friedrich, Michael
Schmittel, Alexander
Henscher, Ulla
Vordermark, Dirk
Diel, Ingo
Freitag, Ulrich
Dietl, Anna
Golatta, Michael
Tholen, Reina
Dannecker, Christian
Gantert, Daniel
Lindel, Katja
Dauelsberg, Timm
Wiedemann, Regina
Paradies, Kerstin
Mustea, Alexander
Steiner, Manfred
AuthorAffiliation 42 ZytoLabor Ludwigsburg, Ludwigsburg, Germany
13 Universitätsspital Basel, Frauenklinik, Basel, Switzerland
15 Universitätsklinikum Heidelberg, Frauenklinik, Heidelberg, Germany
49 Hochtaunus Kliniken, Frauenklinik, Bad Homburg, Germany
36 Universitätsklinikum Magdeburg, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Germany
18 Praxisklinik am Rosengarten, Mannheim, Germany
24 Frauenarztpraxis, Zytologisches Labor, Düsseldorf, Germany
19 Klinikum Ortenau, Frauenklinik, Ortenau, Germany
48 Universitätsklinikum Bonn, Frauenklinik, Bonn, Germany
14 Universitätsklinik Bern, Klinik für Radio-Onkologie, Bern, Switzerland
17 Universitätsklinikum Freiburg, Klinik für Onkologische Rehabilitation, Freiburg, Germany
3 Universitätsklinikum Köln, Frauenklinik, Köln, Germany
43 Labor Schneider, Freiburg im Breisgau, Germany
37 Kliniken Essen-Mitte, Klinik für Palliativmedizin, Essen, Germany
4 Universitätsklinikum Augsburg, Frauenklinik, Augsburg, Germany
21 Universitätsklinikum Halle (Saale), Klinik für St
AuthorAffiliation_xml – name: 41 Kliniken Essen-Mitte, Klinik für Urologie, Essen, Germany
– name: 29 Frauenarztpraxis, Ihringen, Germany
– name: 20 Zentrum für Ultraschalldiagnostik und Pränatalmedizin Frankfurt, Frankfurt am Main, Germany
– name: 14 Universitätsklinik Bern, Klinik für Radio-Onkologie, Bern, Switzerland
– name: 18 Praxisklinik am Rosengarten, Mannheim, Germany
– name: 15 Universitätsklinikum Heidelberg, Frauenklinik, Heidelberg, Germany
– name: 51 Deutsche Krebsgesellschaft e. V., Berlin, Germany
– name: 23 Universitätsklinikum Leipzig, Institut für Pathologie, Leipzig, Germany
– name: 19 Klinikum Ortenau, Frauenklinik, Ortenau, Germany
– name: 33 Helios Klinikum Krefeld, Frauenklinik, Krefeld, Germany
– name: 11 Abteilung für allgemeine Gynäkologie und gynäkologische Onkologie, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medizinische Universität Wien, Wien, Austria
– name: 25 Universitätsklinikum Münster, Frauenklinik, Münster, Germany
– name: 37 Kliniken Essen-Mitte, Klinik für Palliativmedizin, Essen, Germany
– name: 13 Universitätsspital Basel, Frauenklinik, Basel, Switzerland
– name: 21 Universitätsklinikum Halle (Saale), Klinik für Strahlentherapie, Halle (Saale), Germany
– name: 2 Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– name: 47 Konferenz onkologischer Kranken- und Kinderkrankenpflege (KOK), Germany
– name: 1 Universitätsklinikum Düsseldorf, Düsseldorf, Germany
– name: 17 Universitätsklinikum Freiburg, Klinik für Onkologische Rehabilitation, Freiburg, Germany
– name: 28 Praxis für Zytodiagnostik, Cölpin, Germany
– name: 12 Universitätsklinikum AKH-Wien, Klinik für Radioonkologie, Wien, Austria
– name: 39 Universitätsklinikum Köln, Klinik für Radioonkologie, Cyberknife- und Strahlentherapie, Köln, Germany
– name: 7 Charité – Universitätsmedizin Berlin, Klinik für Radioonkologie und Strahlentherapie, Berlin, Germany
– name: 5 SHG-Kliniken Völklingen, Klinik für Radiologie, Völklingen, Germany
– name: 46 Medizinische Hochschule Hannover, Frauenklinik, Hannover, Germany
– name: 43 Labor Schneider, Freiburg im Breisgau, Germany
– name: 8 Universitätsklinikum Hamburg-Eppendorf, II. Medizinische Klinik und Poliklinik, Hamburg, Germany
– name: 22 Städtisches Klinikum Karlsruhe, Klinik für Radioonkologie und Strahlentherapie, Karlsruhe, Germany
– name: 3 Universitätsklinikum Köln, Frauenklinik, Köln, Germany
– name: 42 ZytoLabor Ludwigsburg, Ludwigsburg, Germany
– name: 30 Frauenarztpraxis, Wismar, Germany
– name: 34 Bundesverband Frauenselbsthilfe nach Krebs, Germany
– name: 32 Onkologie Seestrasse, Praxis für Onkologie, Berlin, Germany
– name: 48 Universitätsklinikum Bonn, Frauenklinik, Bonn, Germany
– name: 24 Frauenarztpraxis, Zytologisches Labor, Düsseldorf, Germany
– name: 26 Frauenärzte am Staden, Saarbrücken, Germany
– name: 50 Deutscher Verband für Physiotherapie (ZVK) e. V., Germany
– name: 36 Universitätsklinikum Magdeburg, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Germany
– name: 16 St. Johannes Hospital Dortmund, Klinik für Innere Medizin II, Dortmund, Germany
– name: 27 Labor Dr. Wisplinghoff, Köln, Germany
– name: 49 Hochtaunus Kliniken, Frauenklinik, Bad Homburg, Germany
– name: 44 Wolfgarten Radiologie Bonn, Bonn, Germany
– name: 31 Frauenärzte am Stadtpark, Nürnberg, Germany
– name: 35 Pius Hospital Oldenburg, Klinik für Nuklearmedizin, Oldenburg, Germany
– name: 9 Universitätsklinikum Dresden, Psychoonkologischer Dienst, Dresden, Germany
– name: 40 Universitätsklinikum Schleswig-Holstein, Klinik für Innere Medizin II, Kiel, Germany
– name: 45 Department of Gynecology and Obstetrics, Technische Universität Dresden and National Center for Tumor Diseases (NCT/UCC), Dresden, Germany
– name: 10 Medizinische Klinik und Poliklinik III und Comprehensive Cancer Center (CCC München LMU), Klinikum der Universität München, LMU München, München, Germany
– name: 6 Arbeitsgemeinschaft Deutscher Tumorzentren, Germany
– name: 38 Fliedner Fachhochschule Düsseldorf, Pflegewissenschaft, Düsseldorf, Germany
– name: 4 Universitätsklinikum Augsburg, Frauenklinik, Augsburg, Germany
Author_xml – sequence: 1
  givenname: Tanja
  surname: Fehm
  fullname: Fehm, Tanja
  organization: Universitätsklinikum Düsseldorf, Düsseldorf, Germany
– sequence: 2
  givenname: Frederik A.
  surname: Stübs
  fullname: Stübs, Frederik A.
  organization: Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– sequence: 3
  givenname: Martin C.
  surname: Koch
  fullname: Koch, Martin C.
  organization: Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– sequence: 4
  givenname: Peter
  surname: Mallmann
  fullname: Mallmann, Peter
  organization: Universitätsklinikum Köln, Frauenklinik, Köln, Germany
– sequence: 5
  givenname: Christian
  surname: Dannecker
  fullname: Dannecker, Christian
  organization: Universitätsklinikum Augsburg, Frauenklinik, Augsburg, Germany
– sequence: 6
  givenname: Anna
  surname: Dietl
  fullname: Dietl, Anna
  organization: Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– sequence: 7
  givenname: Anna
  surname: Sevnina
  fullname: Sevnina, Anna
  organization: Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– sequence: 8
  givenname: Franziska
  surname: Mergel
  fullname: Mergel, Franziska
  organization: Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– sequence: 9
  givenname: Laura
  surname: Lotz
  fullname: Lotz, Laura
  organization: Universitätsklinikum Erlangen, Frauenklinik, Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
– sequence: 10
  givenname: Anne
  surname: Ehret
  fullname: Ehret, Anne
  organization: Universitätsklinikum Düsseldorf, Düsseldorf, Germany
– sequence: 11
  givenname: Daniel
  surname: Gantert
  fullname: Gantert, Daniel
  organization: Universitätsklinikum Düsseldorf, Düsseldorf, Germany
– sequence: 12
  givenname: Franca
  surname: Martignoni
  fullname: Martignoni, Franca
  organization: Universitätsklinikum Düsseldorf, Düsseldorf, Germany
– sequence: 13
  givenname: Jan-Philipp
  surname: Cieslik
  fullname: Cieslik, Jan-Philipp
  organization: Universitätsklinikum Düsseldorf, Düsseldorf, Germany
– sequence: 14
  givenname: Jan
  surname: Menke
  fullname: Menke, Jan
  organization: SHG-Kliniken Völklingen, Klinik für Radiologie, Völklingen, Germany
– sequence: 15
  givenname: Olaf
  surname: Ortmann
  fullname: Ortmann, Olaf
  organization: Arbeitsgemeinschaft Deutscher Tumorzentren, Germany
– sequence: 16
  givenname: Carmen
  surname: Stromberger
  fullname: Stromberger, Carmen
  organization: Charité – Universitätsmedizin Berlin, Klinik für Radioonkologie und Strahlentherapie, Berlin, Germany
– sequence: 17
  givenname: Karin
  surname: Oechsle
  fullname: Oechsle, Karin
  organization: Universitätsklinikum Hamburg-Eppendorf, II. Medizinische Klinik und Poliklinik, Hamburg, Germany
– sequence: 18
  givenname: Beate
  surname: Hornemann
  fullname: Hornemann, Beate
  organization: Universitätsklinikum Dresden, Psychoonkologischer Dienst, Dresden, Germany
– sequence: 19
  givenname: Friederike
  surname: Mumm
  fullname: Mumm, Friederike
  organization: Medizinische Klinik und Poliklinik III und Comprehensive Cancer Center (CCC München LMU), Klinikum der Universität München, LMU München, München, Germany
– sequence: 20
  givenname: Christoph
  surname: Grimm
  fullname: Grimm, Christoph
  organization: Abteilung für allgemeine Gynäkologie und gynäkologische Onkologie, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medizinische Universität Wien, Wien, Austria
– sequence: 21
  givenname: Alina
  surname: Sturdza
  fullname: Sturdza, Alina
  organization: Universitätsklinikum AKH-Wien, Klinik für Radioonkologie, Wien, Austria
– sequence: 22
  givenname: Edward
  surname: Wight
  fullname: Wight, Edward
  organization: Universitätsspital Basel, Frauenklinik, Basel, Switzerland
– sequence: 23
  givenname: Kristina
  surname: Loessl
  fullname: Loessl, Kristina
  organization: Universitätsklinik Bern, Klinik für Radio-Onkologie, Bern, Switzerland
– sequence: 24
  givenname: Michael
  surname: Golatta
  fullname: Golatta, Michael
  organization: Universitätsklinikum Heidelberg, Frauenklinik, Heidelberg, Germany
– sequence: 25
  givenname: Volker
  surname: Hagen
  fullname: Hagen, Volker
  organization: St. Johannes Hospital Dortmund, Klinik für Innere Medizin II, Dortmund, Germany
– sequence: 26
  givenname: Timm
  surname: Dauelsberg
  fullname: Dauelsberg, Timm
  organization: Universitätsklinikum Freiburg, Klinik für Onkologische Rehabilitation, Freiburg, Germany
– sequence: 27
  givenname: Ingo
  surname: Diel
  fullname: Diel, Ingo
  organization: Praxisklinik am Rosengarten, Mannheim, Germany
– sequence: 28
  givenname: Karsten
  surname: Münstedt
  fullname: Münstedt, Karsten
  organization: Klinikum Ortenau, Frauenklinik, Ortenau, Germany
– sequence: 29
  givenname: Eberhard
  surname: Merz
  fullname: Merz, Eberhard
  organization: Zentrum für Ultraschalldiagnostik und Pränatalmedizin Frankfurt, Frankfurt am Main, Germany
– sequence: 30
  givenname: Dirk
  surname: Vordermark
  fullname: Vordermark, Dirk
  organization: Universitätsklinikum Halle (Saale), Klinik für Strahlentherapie, Halle (Saale), Germany
– sequence: 31
  givenname: Katja
  surname: Lindel
  fullname: Lindel, Katja
  organization: Städtisches Klinikum Karlsruhe, Klinik für Radioonkologie und Strahlentherapie, Karlsruhe, Germany
– sequence: 32
  givenname: Christian
  surname: Wittekind
  fullname: Wittekind, Christian
  organization: Universitätsklinikum Leipzig, Institut für Pathologie, Leipzig, Germany
– sequence: 33
  givenname: Volkmar
  surname: Küppers
  fullname: Küppers, Volkmar
  organization: Frauenarztpraxis, Zytologisches Labor, Düsseldorf, Germany
– sequence: 34
  givenname: Ralph
  surname: Lellé
  fullname: Lellé, Ralph
  organization: Universitätsklinikum Münster, Frauenklinik, Münster, Germany
– sequence: 35
  givenname: Klaus
  surname: Neis
  fullname: Neis, Klaus
  organization: Frauenärzte am Staden, Saarbrücken, Germany
– sequence: 36
  givenname: Henrik
  surname: Griesser
  fullname: Griesser, Henrik
  organization: Labor Dr. Wisplinghoff, Köln, Germany
– sequence: 37
  givenname: Birgit
  surname: Pöschel
  fullname: Pöschel, Birgit
  organization: Praxis für Zytodiagnostik, Cölpin, Germany
– sequence: 38
  givenname: Manfred
  surname: Steiner
  fullname: Steiner, Manfred
  organization: Frauenarztpraxis, Ihringen, Germany
– sequence: 39
  givenname: Ulrich
  surname: Freitag
  fullname: Freitag, Ulrich
  organization: Frauenarztpraxis, Wismar, Germany
– sequence: 40
  givenname: Tobias
  surname: Gilster
  fullname: Gilster, Tobias
  organization: Frauenärzte am Stadtpark, Nürnberg, Germany
– sequence: 41
  givenname: Alexander
  surname: Schmittel
  fullname: Schmittel, Alexander
  organization: Onkologie Seestrasse, Praxis für Onkologie, Berlin, Germany
– sequence: 42
  givenname: Michael
  surname: Friedrich
  fullname: Friedrich, Michael
  organization: Helios Klinikum Krefeld, Frauenklinik, Krefeld, Germany
– sequence: 43
  givenname: Heidemarie
  surname: Haase
  fullname: Haase, Heidemarie
  organization: Bundesverband Frauenselbsthilfe nach Krebs, Germany
– sequence: 44
  givenname: Marion
  surname: Gebhardt
  fullname: Gebhardt, Marion
  organization: Bundesverband Frauenselbsthilfe nach Krebs, Germany
– sequence: 45
  givenname: Ludwig
  surname: Kiesel
  fullname: Kiesel, Ludwig
  organization: Universitätsklinikum Münster, Frauenklinik, Münster, Germany
– sequence: 46
  givenname: Michael
  surname: Reinhardt
  fullname: Reinhardt, Michael
  organization: Pius Hospital Oldenburg, Klinik für Nuklearmedizin, Oldenburg, Germany
– sequence: 47
  givenname: Michael
  surname: Kreißl
  fullname: Kreißl, Michael
  organization: Universitätsklinikum Magdeburg, Klinik für Radiologie und Nuklearmedizin, Magdeburg, Germany
– sequence: 48
  givenname: Marianne
  surname: Kloke
  fullname: Kloke, Marianne
  organization: Kliniken Essen-Mitte, Klinik für Palliativmedizin, Essen, Germany
– sequence: 49
  givenname: Lars-Christian
  surname: Horn
  fullname: Horn, Lars-Christian
  organization: Universitätsklinikum Leipzig, Institut für Pathologie, Leipzig, Germany
– sequence: 50
  givenname: Regina
  surname: Wiedemann
  fullname: Wiedemann, Regina
  organization: Fliedner Fachhochschule Düsseldorf, Pflegewissenschaft, Düsseldorf, Germany
– sequence: 51
  givenname: Simone
  surname: Marnitz
  fullname: Marnitz, Simone
  organization: Universitätsklinikum Köln, Klinik für Radioonkologie, Cyberknife- und Strahlentherapie, Köln, Germany
– sequence: 52
  givenname: Anne
  surname: Letsch
  fullname: Letsch, Anne
  organization: Universitätsklinikum Schleswig-Holstein, Klinik für Innere Medizin II, Kiel, Germany
– sequence: 53
  givenname: Isabella
  surname: Zraik
  fullname: Zraik, Isabella
  organization: Kliniken Essen-Mitte, Klinik für Urologie, Essen, Germany
– sequence: 54
  givenname: Bernhard
  surname: Mangold
  fullname: Mangold, Bernhard
  organization: ZytoLabor Ludwigsburg, Ludwigsburg, Germany
– sequence: 55
  givenname: Jochen
  surname: Möckel
  fullname: Möckel, Jochen
  organization: Labor Schneider, Freiburg im Breisgau, Germany
– sequence: 56
  givenname: Céline
  surname: Alt
  fullname: Alt, Céline
  organization: Wolfgarten Radiologie Bonn, Bonn, Germany
– sequence: 57
  givenname: Pauline
  surname: Wimberger
  fullname: Wimberger, Pauline
  organization: Department of Gynecology and Obstetrics, Technische Universität Dresden and National Center for Tumor Diseases (NCT/UCC), Dresden, Germany
– sequence: 58
  givenname: Peter
  surname: Hillemanns
  fullname: Hillemanns, Peter
  organization: Medizinische Hochschule Hannover, Frauenklinik, Hannover, Germany
– sequence: 59
  givenname: Kerstin
  surname: Paradies
  fullname: Paradies, Kerstin
  organization: Konferenz onkologischer Kranken- und Kinderkrankenpflege (KOK), Germany
– sequence: 60
  givenname: Alexander
  surname: Mustea
  fullname: Mustea, Alexander
  organization: Universitätsklinikum Bonn, Frauenklinik, Bonn, Germany
– sequence: 61
  givenname: Dominik
  surname: Denschlag
  fullname: Denschlag, Dominik
  organization: Hochtaunus Kliniken, Frauenklinik, Bad Homburg, Germany
– sequence: 62
  givenname: Ulla
  surname: Henscher
  fullname: Henscher, Ulla
  organization: Hochtaunus Kliniken, Frauenklinik, Bad Homburg, Germany
– sequence: 63
  givenname: Reina
  surname: Tholen
  fullname: Tholen, Reina
  organization: Deutscher Verband für Physiotherapie (ZVK) e. V., Germany
– sequence: 64
  givenname: Simone
  surname: Wesselmann
  fullname: Wesselmann, Simone
  organization: Deutsche Krebsgesellschaft e. V., Berlin, Germany
– sequence: 65
  givenname: Matthias W.
  surname: Beckmann
  fullname: Beckmann, Matthias W.
  email: matthias.beckmann@uk-erlangen.de
  organization: Universitätsklinikum Erlangen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35197803$$D View this record in MEDLINE/PubMed
BookMark eNpVkktP3DAUhdOKqgy0K_aVl7RKwI7z3CChmU6mYiioperScpw7EyPHntrJoOzYdt1_yC9pMtAHK8s63z3nXukceHvaaPC8I4JPCI7jUx6QJCVBGEXJS29CIpoFWYajPW-CMUmCOI3Jvnfg3O3wjXKSvPb2aUzyNMN08uJoJvlaGyedj25qsHzTI64rNDdKmbug2yCzQlOwWym4QlOuBdgTVHSyAiU1jGpbA5oVReGj2UWxG55dLNDxVxosYQvKR-ffL-foC6yla22PPpuTh_ufmIanmNKrpY8ueY9CHJL36OH-F7rmtkUhupNtPcwI0zSgK95Kox0yGl27XtQmMFoYZda9PzA1L6WS7Y7x_y0-SqKzFoaV_cFWKTkgW3h25gK4amvBLaA5F6ONBPfGe7XiysHbp_fQ-zb_eDNdBMur4tP0fBkISnAbVJCVJKU0Lmle4iqLy4qIqsRRhuM0zQQATlNa5XEZRqscQwmUkDRL81UioIxieuidPfpuurKBSoBuLVdsY2XDbc8Ml-y5omXN1mbLsiyO84wOBsdPBtb86MC1rJFOgFJcg-kcCxMaDk2gu6x3_2f9DfnThAH48Ai0tYQG2K3prB6uZwSzsWaMs7FmbKwZ_Q2gUMTu
CitedBy_id crossref_primary_10_1016_j_ygyno_2024_03_002
crossref_primary_10_1055_a_1934_1686
crossref_primary_10_1055_a_2134_6740
crossref_primary_10_3390_cancers15184633
crossref_primary_10_3390_cancers15092518
crossref_primary_10_1007_s00432_023_05132_z
crossref_primary_10_1007_s00432_024_05769_4
crossref_primary_10_3390_diagnostics12102436
ContentType Journal Article
Copyright Thieme. All rights reserved.
Thieme. All rights reserved. 2022 Georg Thieme Verlag KG
Copyright_xml – notice: Thieme. All rights reserved.
– notice: Thieme. All rights reserved. 2022 Georg Thieme Verlag KG
CorporateAuthor Carolin C.Hack
CorporateAuthor_xml – name: Carolin C.Hack
DBID 0U6
NPM
7X8
5PM
DOI 10.1055/a-1671-2446
DatabaseName Thieme Connect Journals Open Access
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1438-8804
EndPage 205
ExternalDocumentID 35197803
10_1055_a_1671_2446
Genre Journal Article
GroupedDBID 0R~
0U6
1UC
3O-
4.4
53G
5GY
ABJNI
ABOCM
ACGFS
ACKTL
AENEX
AHRAW
ALMA_UNASSIGNED_HOLDINGS
CS3
DU5
EBS
EJD
F5P
H13
N9A
O9-
OK1
QTC
RIG
ROL
RPM
RTC
X7J
ZXP
NPM
7X8
5PM
ID FETCH-LOGICAL-c310t-de8b17335b39b0d85bd1cdb04805778cee0773d95b24f90ebe3117879f6ceb453
IEDL.DBID RPM
ISSN 0016-5751
IngestDate Tue Sep 17 21:28:15 EDT 2024
Sat Oct 26 04:32:02 EDT 2024
Sat Nov 02 12:15:13 EDT 2024
Sun Nov 24 15:00:51 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Zervixkarzinom
follow-up
Leitlinie
Therapie
therapy
zervikale intraepitheliale Neoplasie
guideline
Nachsorge
cervical cancer
cervical intraepithelial neoplasia
Language English
License Thieme. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c310t-de8b17335b39b0d85bd1cdb04805778cee0773d95b24f90ebe3117879f6ceb453
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1055/a-1671-2446
PMID 35197803
PQID 2632804345
PQPubID 23479
PageCount 25
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8855983
proquest_miscellaneous_2632804345
pubmed_primary_35197803
thieme_journals_10_1055_a_1671_2446
PublicationCentury 2000
PublicationDate 2022-02-01
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-01
  day: 01
PublicationDecade 2020
PublicationPlace Rüdigerstraße 14, 70469 Stuttgart, Germany
PublicationPlace_xml – name: Rüdigerstraße 14, 70469 Stuttgart, Germany
– name: Germany
PublicationTitle Geburtshilfe und Frauenheilkunde
PublicationTitleAlternate Geburtshilfe Frauenheilkd
PublicationYear 2022
Publisher Georg Thieme Verlag KG
Publisher_xml – name: Georg Thieme Verlag KG
SSID ssj0014916
Score 2.3583655
Snippet Abstract Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL),...
This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published in...
Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published...
Aim This is an update of the interdisciplinary S3-guideline on the Diagnosis, Therapy and Follow-up of Cervical Cancer (AWMF Registry No. 032/033OL), published...
SourceID pubmedcentral
proquest
pubmed
thieme
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 181
SubjectTerms GebFra Science
Title Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities
URI http://dx.doi.org/10.1055/a-1671-2446
https://www.ncbi.nlm.nih.gov/pubmed/35197803
https://www.proquest.com/docview/2632804345
https://pubmed.ncbi.nlm.nih.gov/PMC8855983
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFDd0QogLgvFVvvQQHECKGyeOm-Q4NWsrbR0TG4JbFH-EVaJJtbZCu-3Kmf9wfwl-TjJW7cbZzpMT__z8nPfz7xHyQZtSRyKM6JBzQ6NQMyqVNHa5YwGONCwDJ5I0PYmPvifZPsrkiO4ujCPtKzkfVD8Xg2p-5riVy4XyO56YfzwbJQnKinO_R3o2NuyO6G3qIEpdvVOMZSgmFdpLeUwIv6DBMA6o3dGwchGWposTVy3rVmx5myJ5b302NwtzY_MZPyIP26gR9prRPSZ3TbVL7s_avPiTO7tZw5ibrzw4bXQCoKg0jO0s17_oZgl1CSPnFqyZEc70-QAmG9S4sgaw1QaCkE0mEw-yg4l7ODuYwscTTg-RV-TB3rfZGL6YH648HBzVg6vL34yHPuP886EHs-ICQruVf4Kryz9wbD8khIB_eQFPuIuFaas3raCuoHG7tK6cZvaFZ_vcFAz3_g0cm5TTkFLGs2bx7xB66K3XnF6T2GBcKDRjz_9Pydfx_uloSttyD1TZGHNNtUlkEHMuJE8l04mQOlBa4qV3EceJ3c1ZHHOdChlGZcos-ngQWH-TlkNlZCT4M7JT1ZV5QaBggpWhYmlhIpSMT5V1pkGqZGDDIc2jPnnXTXlulxPmSIrK1JtVjvL1CYt4JPrkeQOBfNnofuQdYPok3gLHdQeU6t5usQh2kt0tYvvkfQOjvPUUq9yRAITIixyxmSM2X_63_VfkQYjXMxyr_DXZWZ9vzBvSW-nNW7dI_gKGZBXB
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEDbsgoALj-VVnoPgAFLcOHHcJMdVu21RH6zYIrhFseOwlWhSbVqhve2VM_9wfwkeJ1222tuexxk50ufx2PP5G0I-ZDrPAuEHtMO5poGfMSqV1Ga5YwOO2M89K5I0PAqnP6LeAcrkiM1bGEvaV3LeLn4t2sX82HIrlwvlbnhi7uGkG0UoK87dHXLLrFfGNof0pngQxLbjKWYzFMsKzbM8JoSbUq8TetTsadi7CJvThZHtl3Ulu7xKkry9Op7rhb60_fQfXHPiD8n9Jt-E_dr8iNzUxR65M2kq6o9v7PVqrt28cmBWKwxAWmTQN_gof9P1EsocujagGDddxMhJGwZrVMcyDtBqUkjoDQYDB3qjgf24NxrCxyNOx8hIcmD_-6QPX_VP21gOpmX7_OwP477LOP8ydmCSnoJvkoBPcH72Fw7Nn4APeD8MeDZeLHTT96mCsoA6YNOysGrbp44Zc1lq3Pk_cTQpqz6ltGPc4r0Sxvat3xxe0N-gnyp0M9fVE_KtfzDrDmnTKIIqk52uaKYj6YWcC8ljybJIyMxTmcTn8iIMI5MHsDDkWSykH-QxM7jlnmciVZx3lJaB4E_JblEW-jmBlAmW-4rFqQ5QbD5WJgx7sZKeSaQyHrTIuw1UErMQsbqSFrpcVwkK30cs4IFokWc1dJJlrRiSbIDWIuEWqC4GoMj3tsVAyIp9N5Bpkfc1_JImxlSJpQ8IkaQJYjpBTL-4tv-35O5wNhkn48_T0Utyz8dHHpab_orsrk7W-jXZqbL1G7vQ_gEaWStX
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFDW0oIoNj_IanhfBAqR44sTxJFlWk2YGzYOKFsEuSmKHjsQko2ZGqLtuWfOH_RJ8nczQUXewtnPlSMfX1_bxOYS8k6qQnnA92uNcUc-VjGZ5pvR0RwOO0C0cI5I0PPan34LoEGVyNlZfhrSfZ7Nu-WPeLWenhlu5mOf2midmH036QYCy4txeyMLeIbf0nGXueqPeXiB4oXE9xYqG4tVC-zSPCWGn1On5DtXrGvoXoUGdHxjPrGsV5nWi5O3l6UzN1ZUlKL73H4O_T-62dSccNF0ekJuq3Cd7k_Zm_eGN_ajh3M1qC04apQFISwmxxkn1k64WUBXQN4lFh-kjVs66MFihSpYOgK26lIRoMBhYEI0G5uNoNIT3x5yOkZlkwcHXSQyf1XdjMAfTqnt58Ytx12acfxpbMEnPwdXFwAe4vPgNR_pvwAU8JwbcI8_nqvV_qqEqoUnctCqN6va5pftclRy3_g4cm3KjQpUrS4fF8yXM8Vu_OdzQ4CBOcwwzU_Uj8iU-POkPaWsYQXNdpS6pVEHm-JyLjIcZk4HIpJPLDJ_NC98PdD3AfJ_LUGSuV4RM45c7js5YYdHLVeYJ_pjsllWpnhJImWCFm7MwVR6Kzoe5TsdOmGeOLqgk9zrkzRouiZ6QeMuSlqpa1QkK4AfM457okCcNfJJFoxySrMHWIf4WsDYdUOx7u0XDyIh-t7DpkLcNBJM219SJoREIkaQJ4jpBXD_75_ivyd5RFCfjj9PRc3LHxbcehqL-guwuz1bqJdmp5eqVmWt_AIOlLdc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnosis%2C+Therapy+and+Follow-up+of+Cervical+Cancer.+Guideline+of+the+DGGG%2C+DKG+and+DKH+%28S3-Level%2C+AWMF+Registry+No.%E2%80%89032%2F033OL%2C+May+2021%29+-+Part+2+with+Recommendations+on+Psycho-oncology%2C+Rehabilitation%2C+Follow-up%2C+Recurrence%2C+Palliative+Therapy+and+Healthcare+Facilities&rft.jtitle=Geburtshilfe+und+Frauenheilkunde&rft.au=Fehm%2C+Tanja&rft.au=St%C3%BCbs%2C+Frederik+A&rft.au=Koch%2C+Martin+C&rft.au=Mallmann%2C+Peter&rft.date=2022-02-01&rft.issn=0016-5751&rft.volume=82&rft.issue=2&rft.spage=181&rft_id=info:doi/10.1055%2Fa-1671-2446&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0016-5751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0016-5751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0016-5751&client=summon